4
Changes in Ownership
IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001104659-23-109941
Chief Operating Officer gave up 1,395 shares (to pay taxes)
- Chief Operating Officer acquired 2,813 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BILINSKY IGOR Chief Operating Officer | 2023-10-16 | Option exercise | +2,813 | 30,026 | D | ||
| BILINSKY IGOR Chief Operating Officer | 2023-10-16 | Shares withheld for taxes | −1,395 | $3.57 | $4,980 | 28,631 | D |
| Derivatives | |||||||
| BILINSKY IGOR Chief Operating Officer | 2023-10-16 | Option exercise · Restricted Stock Units | −2,813 | 14,064 | D | ||
Loading xslF345X05/tm2328751-2_4seq1.xml…